Clinical Trials Directory

Trials / Completed

CompletedNCT03711383

Inulin and Acetate Production and Human Substrate Metabolism

The Effects of Inulin on Acetate Production and Human Substrate Metabolism

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
Male
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

Based on our hypothesis that orally administered resistant starch and inulin/beta glucan will be fermented into a SCFA pattern high in acetate and that this will lead to beneficial effects on human substrate and energy metabolism, we aim to address the following primary objective: To investigate the effects of an acute administration of inulin/beta glucan in combination with resistant starch on fecal and plasma acetate, as well as on fasting and postprandial substrate and energy metabolism in lean normoglycemic men and obese, prediabetic men.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTInulin and Resistant Starch12g per inulin in combination 7.5 g resistant starch per day the day before the CID Resistant starch 7.5 g
DIETARY_SUPPLEMENTInulin12g per inulin in combination with maltodextrin per day the day before the CID
DIETARY_SUPPLEMENTPlaceboisocaloric maltodextrin before test day

Timeline

Start date
2018-02-20
Primary completion
2018-11-15
Completion
2018-11-15
First posted
2018-10-18
Last updated
2020-01-14

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT03711383. Inclusion in this directory is not an endorsement.